News

New research could improve the effectiveness of flu vaccines and therapies

Scientists at Scripps Research have solved a cellular mystery that may have important implications for fundamental biology and diseases like ALS.

World-class research institute and new innovation center partner to accelerate early translational research.

The next step in this research will be to license the vaccine to an outside company for partnering in clinical trials.

Matthew Disney is a finalist for the prestigious Blavatnik National Awards for Young Scientists.

"This was a tenacious effort—over a decade—to conquer a global threat."

"Joel’s professional experience and business leadership add to the expertise of our current board members."

Assistant Professor Seth Tomchik of the Florida campus of The Scripps Research Institute (TSRI) has received $2 million in funding from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS).

Like a flu vaccine, an effective HIV vaccine needs to protect against multiple strains.

Scientists at Scripps Research have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.

A discovery by scientists at Scripps Research may provide a new therapy that can stop the neurotoxin even in its more severe, advanced stages of action.

With mosquito season looming in the Northern Hemisphere, doctors and researchers are poised to take on a new round of Zika virus infections.

The Nuclear Magnetic Resonance (NMR) facility at the Florida campus of Scripps Florida is becoming one of the most advanced in South Florida, thanks to a new $600,000 grant from the National Institutes of Health.

Scripps Research Graduate Program Marks 25th Commencement with Two Honorary Degree Recipients

Three chemists from Scripps Research—Dale Boger, Jin-Quan Yu and Phil Baran—have received awards from the Royal Society of Chemistry.

“Since this is a major pathway for diseases like cancer and fibrosis, our findings add a brand-new layer of valuable information."

Scientists at Scripps Research have discovered why some cancers may reoccur after years in remission.

San Diego researchers Ardem Patapoutian and Phil Baran receive one of science’s highest honors

Scientists from the Florida campus of Scripps Research have shown that a protein helps balance nerve cell communication.

Leaders in basic and translational research at TSRI and Calibr will provide target materials and relevant know‐how to prosecute drug targets of interest.

Brain cells appear less vulnerable to DNA damage than previously thought, according to a new study led by scientists at Scripps Research.

Scientists at Scripps Research in La Jolla have revealed new clues to the wiring of the brain.

New method expected to replace textbook reactions, enable syntheses of many new candidate drugs and other molecules.

Initial demonstrations yield compounds with promise for treating COPD, cystic fibrosis and other lung disorders.